APA

Fuchs S. A., De Barse M. M. J., Scheepers F. E., Cahn W., Dorland L., de Sain-van der Velden M. G., Klomp L. W. J., Berger R., Kahn R. S. & de Koning T. J. (20080702). Cerebrospinal fluid D-serine and glycine concentrations are unaltered and unaffected by olanzapine therapy in male schizophrenic patients. : European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology.

Chicago

Fuchs Sabine A, De Barse Martina M J, Scheepers Floor E, Cahn Wiepke, Dorland Lambertus, de Sain-van der Velden Monique G, Klomp Leo W J, Berger Ruud, Kahn René S and de Koning Tom J. 20080702. Cerebrospinal fluid D-serine and glycine concentrations are unaltered and unaffected by olanzapine therapy in male schizophrenic patients. : European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology.

Harvard

Fuchs S. A., De Barse M. M. J., Scheepers F. E., Cahn W., Dorland L., de Sain-van der Velden M. G., Klomp L. W. J., Berger R., Kahn R. S. and de Koning T. J. (20080702). Cerebrospinal fluid D-serine and glycine concentrations are unaltered and unaffected by olanzapine therapy in male schizophrenic patients. : European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology.

MLA

Fuchs Sabine A, De Barse Martina M J, Scheepers Floor E, Cahn Wiepke, Dorland Lambertus, de Sain-van der Velden Monique G, Klomp Leo W J, Berger Ruud, Kahn René S and de Koning Tom J. Cerebrospinal fluid D-serine and glycine concentrations are unaltered and unaffected by olanzapine therapy in male schizophrenic patients. : European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 20080702.